305 related articles for article (PubMed ID: 24000874)
1. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
[TBL] [Abstract][Full Text] [Related]
2. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.
Soto ME; Secher M; Gillette-Guyonnet S; Abellan van Kan G; Andrieu S; Nourhashemi F; Rolland Y; Vellas B
J Alzheimers Dis; 2012; 28(3):647-54. PubMed ID: 22045479
[TBL] [Abstract][Full Text] [Related]
3. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study.
Onder G; Penninx BW; Balkrishnan R; Fried LP; Chaves PH; Williamson J; Carter C; Di Bari M; Guralnik JM; Pahor M
Lancet; 2002 Mar; 359(9310):926-30. PubMed ID: 11918911
[TBL] [Abstract][Full Text] [Related]
4. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme serum activities: Relationship with Alzheimer's disease.
Zhuang S; Wang X; Wang HF; Li J; Wang HY; Zhang HZ; Xing CM
Brain Res; 2016 Nov; 1650():196-202. PubMed ID: 27608957
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease risk factors and progression of Alzheimer's disease.
Abellan van Kan G; Rolland Y; Nourhashémi F; Coley N; Andrieu S; Vellas B
Dement Geriatr Cogn Disord; 2009; 27(3):240-6. PubMed ID: 19246908
[TBL] [Abstract][Full Text] [Related]
7. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.
Edwards JD; Ramirez J; Callahan BL; Tobe SW; Oh P; Berezuk C; Lanctôt K; Swardfager W; Nestor S; Kiss A; Strother S; Black SE;
J Alzheimers Dis; 2017; 59(3):1113-1122. PubMed ID: 28731439
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
[TBL] [Abstract][Full Text] [Related]
11. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
[TBL] [Abstract][Full Text] [Related]
12. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.
Mossello E; Pieraccioli M; Nesti N; Bulgaresi M; Lorenzi C; Caleri V; Tonon E; Cavallini MC; Baroncini C; Di Bari M; Baldasseroni S; Cantini C; Biagini CA; Marchionni N; Ungar A
JAMA Intern Med; 2015 Apr; 175(4):578-85. PubMed ID: 25730775
[TBL] [Abstract][Full Text] [Related]
13. Long-term progression of Alzheimer's disease in patients under antidementia drugs.
Gillette-Guyonnet S; Andrieu S; Nourhashemi F; Gardette V; Coley N; Cantet C; Gauthier S; Ousset PJ; Vellas B;
Alzheimers Dement; 2011 Nov; 7(6):579-92. PubMed ID: 22055975
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
Anderson C; Teo K; Gao P; Arima H; Dans A; Unger T; Commerford P; Dyal L; Schumacher H; Pogue J; Paolasso E; Holwerda N; Chazova I; Binbrek A; Young J; Yusuf S;
Lancet Neurol; 2011 Jan; 10(1):43-53. PubMed ID: 20980201
[TBL] [Abstract][Full Text] [Related]
15. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression].
Ohrui T
Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.
Sink KM; Leng X; Williamson J; Kritchevsky SB; Yaffe K; Kuller L; Yasar S; Atkinson H; Robbins M; Psaty B; Goff DC
Arch Intern Med; 2009 Jul; 169(13):1195-202. PubMed ID: 19597068
[TBL] [Abstract][Full Text] [Related]
17. Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.
O'Caoimh R; Healy L; Gao Y; Svendrovski A; Kerins DM; Eustace J; Kehoe PG; Guyatt G; Molloy DW
J Alzheimers Dis; 2014; 40(3):595-603. PubMed ID: 24496072
[TBL] [Abstract][Full Text] [Related]
18. Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population.
Rygiel K
J Postgrad Med; 2016; 62(4):242-248. PubMed ID: 27763482
[TBL] [Abstract][Full Text] [Related]
19. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.
Handels RL; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FR; Severens JL; Fratiglioni L; Joore MA; Wimo A
J Alzheimers Dis; 2013; 37(2):357-65. PubMed ID: 23948894
[TBL] [Abstract][Full Text] [Related]
20. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
